Marksans Pharma Limited has informed the Exchange about schedule of a conference call for analysts and investors on Friday, February 06, 2026 at 04:00 PM (IST) to discuss the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended December 31, 2025
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has scheduled a conference call for analysts and investors on Friday, February 6, 2026, at 4:00 PM IST. The call will cover the company's unaudited financial results, both standalone and consolidated, for the quarter ended December 31, 2025 (Q3 FY26). This is a standard post-earnings engagement where management typically walks through key financial metrics, business updates, and outlook. Retail investors can listen in or check the company's website later for the call replay and presentation materials.
This is a routine investor engagement with no direct impact on stock price. However, guidance or commentary shared during the call could influence near-term investor sentiment around the Q3 results.